Mobile
Recherche simple
Recherche avancée
Recherche multicritère
Qui sommes-nous ?
Connexion
Inscription
French
English
Kusajili – Centralise les essais cliniques mondiaux
Résultat
de votre recherche par promoteur : Astellas Pharma
Femme et Homme Max 99 ans
Astellas Pharma Europe B.V
MAJ Il y a 4 ans
Roxadustat in the Treatment of Anemia in Chronic Kidney Disease Patients
To evaluate the efficacy of roxadustat in the treatment of anemia in non-dialysis Chronic Kidney Disease (CKD) subjects.
Pays
Aucun
Organes
Aucun
Spécialités
Aucune
unknown
Plus d'informations
Femme et Homme Max 99 ans
Astellas Pharma Europe B.V
MAJ Il y a 4 ans
A PHASE IV, OPEN LABEL, PILOT STUDY OF THE TREATMENT OF CHILDREN WITH MODERATE TO SEVERE ATOPIC DERMATITIS (AD) USING LOCOBASE REPAIR® AS AN ADJUNCTIVE TO STANDARD TREATMENT
To assess the efficacy of Locobase REPAIR® when used in children with moderate to severe AD
Pays
Aucun
Organes
Aucun
Spécialités
Aucune
unknown
Plus d'informations
Femme et Homme Max 99 ans
Astellas Pharma Europe B.V
MAJ Il y a 4 ans
Study to compare the mirabegron concentrations in blood after administration of mirabegron as tablet and oral suspension in healthy subjects and to evaluate the food effect
To assess the bioavailability of 50 mg mirabegron oral suspension relative to that of the 50 mg mirabegron modified release tablet when dosed under fasted conditions.
Pays
Aucun
Organes
Aucun
Spécialités
Aucune
Essai clos aux inclusions
Plus d'informations
Femme Max 99 ans
Astellas Pharma Europe B.V
MAJ Il y a 4 ans
A study to assess the effectiveness and safety of different doses of ASP1707 compared to placebo for endometriosis associated pelvic pain
- to assess the efficacy and dose-response relationship of ASP1707 in reduction of endometriosis associated pelvic pain.
Pays
Aucun
Organes
Aucun
Spécialités
Aucune
Essai clos aux inclusions
Plus d'informations
Homme Max 99 ans
Astellas Pharma Europe B.V
MAJ Il y a 4 ans
A phase IIIb randomized study of intermittent versus continuous androgen deprivation therapy using ELIGARD 22.5 mg 3-month depot in subjects with relapsing or locally advanced prostate cancer who are responsive to such therapy
To assess prostate-specific antigen (PSA) and testosterone levels after continuous and intermittent androgen deprivation therapy and compare time to PSA progression.
Pays
Aucun
Organes
Aucun
Spécialités
Aucune
Essai clos aux inclusions
Plus d'informations
Femme et Homme Max 99 ans
Astellas Pharma Europe Ltd
MAJ Il y a 4 ans
AN OPEN, RANDOMISED, MULTICENTRE, EXPLORATORY CLINICAL STUDY TO COMPARE THE SAFETY AND EFFICACY OF TACROLIMUS IN COMBINATION WITH MONOCLONAL ANTI-IL2R ANTIBODIES OR STEROIDS IN HCV POSITIVE PATIENTS UNDERGOING LIVER ALLOGRAFT TRANSPLANTATION
The objective of this exploratory study is to evaluate the impact of the elimination of the steroid administration upon viral HCV load at 12 months measured by quantitative serum HCV-RNA determination...
Pays
Aucun
Organes
Aucun
Spécialités
Aucune
Essai clos aux inclusions
Plus d'informations
Femme et Homme Max 99 ans
Astellas Pharma Global Development, Inc (APGD)
MAJ Il y a 4 ans
This is a phase 3, open-label, multicenter, randomized study to compare the efficacy and safety of ASP2215 therapy to salvage chemotherapy in FLT3-mutated AML subjects who are refractory to or have relapsed after first-line AML therapy
The primary objective is to determine the clinical benefit of ASP2215 therapy in subjects with FMS-like tyrosine kinase (FLT3) mutated AML who are refractory to or have relapsed after first-line AML t...
Pays
Aucun
Organes
Aucun
Spécialités
Aucune
unknown
Plus d'informations
Femme et Homme Max 99 ans
Astellas Pharma Global Development, Inc
MAJ Il y a 4 ans
Lintisinib rollover study
The objective of the study is to provide treatment continuation for subjects participating in other Astellas-sponsored studies with linsitinib.
Pays
Aucun
Organes
Aucun
Spécialités
Aucune
Essai clos aux inclusions
Plus d'informations
Femme et Homme Max 99 ans
Astellas Pharma Europe Ltd
MAJ Il y a 4 ans
An Exploratory Study to Compare the Efficacy and Safety of Micafungin as a Pre-emptive Treatment of Invasive Candidiasis versus Placebo in High Risk Surgical Subjects with Intra-abdominal Infections - A Multicentre, Randomized, Double-Blind Study
assess the incidence of invasive candidiasis at EOT assess the time to invasive candidiasis at EOT
Pays
Aucun
Organes
Aucun
Spécialités
Aucune
Essai clos aux inclusions
Plus d'informations
Homme Max 99 ans
Astellas Pharma Europe Ltd. (APEL)
MAJ Il y a 4 ans
A study in patients with metastatic prostate cancer to assess how the drug Eligard®, affects certain markers in blood and urine, which are indicators for the disease. Een onderzoek in patiënten met uitgezaaid prostaatkanker om te bepalen hoe het geneesmiddel Eligard®, bepaalde markers in bloed en urine, die indicatief zijn voor de ziekte, beinvloedt
To explore the effect of Eligard® on the following prostate cancer biomarkers: • Testosterone in serum • Prostate Specific Antigen (PSA) in serum • Prostate Cancer Antigen (PCA3) in urine • PSA m...
Pays
Aucun
Organes
Aucun
Spécialités
Aucune
Essai clos aux inclusions
Plus d'informations
Précédent
3
4
5
6
7
8
9
10
11
12
Suivant